Canadian XRP ETF options receive regulatory clearance for offering to eligible U.S. investors.

The Canadian Derivatives Clearing Corporation disclosed the registrations in a Form 8-K dated September 9, 2026, identifying the Evolve XRP ETF and Purpose XRP ETF as the underlying products.
The ETFs trade under the tickers XRP (Evolve XRP ETF) and XRPP (Purpose XRP ETF) on the Montréal Exchange, and their options are covered by CDCC’s Form S-20 registration.
National Bank of Canada disclosed an approximately $330,000 investment in the Bitwise XRP ETF, while Bank of Montreal also reported investments in XRP-related products as part of broader portfolio diversification.
The relevant Federal Register framework involved both the Securities and Exchange Commission and the Commodity Futures Trading Commission, which classified XRP alongside Bitcoin, Ether and Solana as meeting generic standards for commodity-based trust shares; the articles note that this is not a blanket declaration that every XRP transaction is a commodity transaction.
Earlier 2026 SEC exhibits had already named the Evolve and Purpose XRP ETF options, meaning the latest CDCC filing reaffirms an existing regulatory pathway rather than creating the first U.S. approval for the contracts.
Canadian XRP ETF options have been approved for sale to U.S. investors, expanding regulated access to the cryptocurrency without requiring direct ownership. Crypto News reported that the Canadian Derivatives Clearing Corporation registered options tied to the Evolve XRP ETF and Purpose XRP ETF through a Form S-20 framework, giving institutions a way to hedge or trade XRP exposure through derivatives cleared in Canada.
The approval places XRP alongside Bitcoin, Ether, and Solana within a regulated digital-asset derivatives infrastructure. CryptoNews.net noted that the two Canadian-listed ETFs—trading under tickers XRP and XRPP on the Montréal Exchange—now offer options to eligible U.S. investors, reinforcing an existing cross-border regulatory pathway rather than launching an entirely new U.S. product.
The Canadian Derivatives Clearing Corporation disclosed the registrations in a Form 8-K filing dated September 9, 2026. U.Today reported that the options remain listed on the Montréal Exchange and cleared in Canada, meaning they do not represent a new U.S. exchange launch. Instead, the structure creates a regulated bridge for institutions to gain XRP exposure without holding the cryptocurrency directly or relying on offshore derivatives markets.
Institutional adoption of XRP products is accelerating in Canada. National Bank of Canada disclosed an approximately $330,000 investment in the Bitwise XRP ETF, while Bank of Montreal reported investments in XRP-related products as part of broader portfolio diversification. These moves signal growing confidence in regulated XRP exposure among traditional financial institutions.
The SEC and Commodity Futures Trading Commission classified XRP alongside Bitcoin, Ether, and Solana as meeting generic standards for commodity-based trust shares. Crypto.news clarified that this designation applies specifically to these regulated ETF products and does not mean every XRP transaction is classified as a commodity. Earlier 2026 SEC exhibits had already named the Evolve and Purpose XRP ETF options, meaning the latest filing reaffirms an existing regulatory pathway.
While options access expands, other XRP derivative products face delays. U.Today reported that the proposed Teucrium 2x Short Daily XRP ETF, listed by Listed Funds Trust, was pushed back from an October 11, 2026 launch date to the following month. The short ETF would allow investors to profit if XRP prices decline, adding another tool to the growing suite of regulated XRP financial products.
Publishers
16
Articles
3
Reach
19